Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2241-2021Class II

Kaluza C Flow Cytometry Software Versions: 1.0*, 1.1.1 and 1.1.2 Kits: C10574 - Kaluza C Single Perpetual...

Siemens Healthcare Diagnostics Inc. / initiated 2021-06-23 / Terminated / root cause: software

Beckman Coulter, Inc. began a recall of Kaluza C Flow Cytometry Software Versions: 1.0*, 1.1.1 and 1.1.2 Kits: C10574 - Kaluza C Single Perpetual License C10575 - Kaluza C Single User 1-year License... on . FDA classified it as Class II and gives the reason as "Software anomalies that may lead to the generation of erroneous results". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-2241-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
Kaluza C Flow Cytometry Software Versions: 1.0*, 1.1.1 and 1.1.2 Kits: C10574 - Kaluza C Single Perpetual License C10575 - Kaluza C Single User 1-year License C10576 - Kaluza C 10 User Network License C10577 - Kaluza C 5 User Network License C10578 - Kaluza C Single Perpetual Educational License C10579 - Kaluza C Single User 1-year Educational License C10580 - Kaluza C 10 User Network Educational License C10581 - Kaluza C 5 User Network Educational License and C21166 - Kaluza C Program DVD v1.0
Product code
JQP Calculator/Data Processing Module, For Clinical Use
Reason for recall
Software anomalies that may lead to the generation of erroneous results.
Root cause tag
software
FDA root cause
Under Investigation by firm
Action
The firm notified its consignees via mail and email on 06/28/2021. Customers were provided with actions to take via customer letter. New customers will be affected by the issue. A stuffer letter will be implemented in new product to notify new customers. New customers downloading Kaluza software from the website will be notified of the issue via email during the downloading process. Product Disposition: A Stop Ship was placed on Kaluza software in order to implement the letter in new kits.
Quantity in commerce
1,085 (482 US & 603 OUS)
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, FL, GA, IL, IN, KS, LA, MA, MD, ME, MI, MN, MS, NC, NE, NJ, NV, NY, OH, OK, OR, PA, TN, TX, UT, VA, WA, WI, WV, and Hawaii. The countries of Australia, Austria, Bahrain, Belgium, Bolivia, Brazil, Canada, China, Czech Republic, Denmark, Ecuador, Egypt, France, Germany, Greece, Guadeloupe, Hong Kong, Hungary, India, Israel, Italy, Kenya, Korea, Kuwait, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Panama, Peru, Poland, Portugal, Reunion, Saudi Arabia, Slovakia, South Africa, Sweden, Switzerland, Taiwan, Thailand, Tunisia, U.A.E, Ukraine, United Kingdom, and Vietnam.
Product codes and lots
Versions: 1.0, 1.1.1 and 1.1.2

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2241-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2241-2021Class IITerminatedVoluntary: Firm initiated